Literature DB >> 7834433

Modulation of oncogene and tumor-suppressor gene expression: a novel strategy for cancer prevention and treatment.

J A Roth1.   

Abstract

BACKGROUND: Advances in our understanding of the molecular biology of cancer have the potential for translation into clinical cancer prevention and treatment strategies. Oncogenes and tumor suppressor genes have been implicated in the development of human cancers Mutations in gene families occur in both premalignant lesions and invasive tumors.
CONCLUSION: Recombinant DNA constructs can be made that eliminate expression of a mutant oncogene protein or provide a normal copy of a tumor suppressor gene to the cancer cell. Reversal of a single genetic lesion is sufficient to inhibit cancer cell proliferation and tumorigenicity. Viral vectors are now being evaluated for direct delivery of these constructs to human tumors.

Entities:  

Mesh:

Year:  1994        PMID: 7834433     DOI: 10.1007/bf02303545

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  40 in total

1.  Genetic mechanisms of tumor suppression by the human p53 gene.

Authors:  P L Chen; Y M Chen; R Bookstein; W H Lee
Journal:  Science       Date:  1990-12-14       Impact factor: 47.728

2.  Specific inhibition of K-ras expression and tumorigenicity of lung cancer cells by antisense RNA.

Authors:  T Mukhopadhyay; M Tainsky; A C Cavender; J A Roth
Journal:  Cancer Res       Date:  1991-03-15       Impact factor: 12.701

3.  High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene.

Authors:  A Lavigueur; V Maltby; D Mock; J Rossant; T Pawson; A Bernstein
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

Review 4.  The p53 tumour suppressor gene.

Authors:  A J Levine; J Momand; C A Finlay
Journal:  Nature       Date:  1991-06-06       Impact factor: 49.962

5.  Adenocarcinoma and Barrett's esophagus. An overrated risk?

Authors:  S J Spechler; A H Robbins; H B Rubins; M E Vincent; T Heeren; W G Doos; T Colton; E M Schimmel
Journal:  Gastroenterology       Date:  1984-10       Impact factor: 22.682

6.  Archival analysis of p53 genetic and protein alterations in Chinese esophageal cancer.

Authors:  W P Bennett; M C Hollstein; A He; S M Zhu; J H Resau; B F Trump; R A Metcalf; J A Welsh; C Midgley; D P Lane
Journal:  Oncogene       Date:  1991-10       Impact factor: 9.867

7.  A codon 248 p53 mutation retains tumor suppressor function as shown by enhancement of tumor growth by antisense p53.

Authors:  T Mukhopadhyay; J A Roth
Journal:  Cancer Res       Date:  1993-09-15       Impact factor: 12.701

8.  Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners.

Authors:  K H Vähäkangas; J M Samet; R A Metcalf; J A Welsh; W P Bennett; D P Lane; C C Harris
Journal:  Lancet       Date:  1992-03-07       Impact factor: 79.321

9.  Increased expression of mutant forms of p53 oncogene in primary lung cancer.

Authors:  R Iggo; K Gatter; J Bartek; D Lane; A L Harris
Journal:  Lancet       Date:  1990-03-24       Impact factor: 79.321

10.  p53 gene mutations in esophageal cancer detected by polymerase chain reaction single-strand conformation polymorphism analysis.

Authors:  G Tamura; C Maesawa; Y Suzuki; R Satodate; K Ishida; K Saito
Journal:  Jpn J Cancer Res       Date:  1992-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.